Background-Dysregulation of voltage-gated cardiac Na + channels (Na V 1.5) by inherited mutations, disease-linked remodeling, and drugs causes arrhythmias. The molecular mechanisms whereby the Na V 1.5 voltage-sensing domains (VSDs) are perturbed to pathologically or therapeutically modulate Na + current (I Na ) have not been specified. Our aim was to correlate I Na kinetics with conformational changes within the 4 (DI-DIV) VSDs to define molecular mechanisms of Na V 1.5 modulation. Method and Results-Four Na V 1.5 constructs were created to track the voltage-dependent kinetics of conformational changes within each VSD, using voltage-clamp fluorometry. Each VSD displayed unique kinetics, consistent with distinct roles in determining I Na . In particular, DIII-VSD deactivation kinetics were modulated by depolarizing pulses with durations in the intermediate time domain that modulates late I Na . We then used the DII-VSD construct to probe the molecular pathology of 2 Brugada syndrome mutations (A735V and G752R). A735V shifted DII-VSD voltage dependence to depolarized potentials, whereas G752R significantly slowed DII-VSD kinetics. Both mutations slowed I Na activation, although DII-VSD activation occurred at higher potentials (A735V) or at later times (G752R) than ionic current activation, indicating that the DII-VSD allosterically regulates the rate of I Na activation and myocyte excitability. Conclusions-Our results reveal novel mechanisms whereby the Na V 1.5 VSDs regulate channel activation and inactivation.
A trial and ventricular action potentials are initiated by a large membrane-depolarizing Na + flux through the cardiac voltage-gated Na + channel (Na V 1.5). In large animals and humans, persistent Na V 1.5 current is also a significant regulator of action potential duration. Because of its central role in determining the action potential, molecular-level interactions that perturb Na V 1.5 channel function have a significant effect on the ability of the myocardium to initiate and sustain arrhythmias. Mutations to Na V 1.5 are known to cause long QT syndrome type 3, Brugada syndrome (BrS), sick sinus syndrome, atrial fibrillation, and familial heart block. 1, 2 Furthermore, class I small molecule antiarrhythmics target the Na V 1.5 pore with the aim of diminishing Na + current to prevent arrhythmia. 3 To date, characterization of Na V 1.5 mutation pathology and drug interactions has primarily relied on measuring the ionic current response to elaborately designed voltage-pulse protocols. Here, we develop novel Na V 1.5 constructs to augment these protocols by monitoring changes in conformation with fluorescence labeling, at the same time we observe the ionic current, with voltage-clamp fluorometry (VCF). By applying VCF to observe channels that carry inherited mutations, we expect to improve phenotypic precision by characterizing the molecular pathology of the disease.
The Na V 1.5 α-subunit, encoded by SCN5A, is composed of 4 homologous domains (DI-DIV), each with 6 transmembrane-spanning segments (S1-S6). Within DI-DIV, S1-S4 form the voltage-sensing domains (VSDs), which respond to changes in membrane potential (V m ) to cause Na V 1.5 gating. The Na V 1.5 pore is formed by the S5-S6 segments. A hydrophobic triplet located in the intracellular DIII/DIV linker is required for inactivation, 4 and its action is modulated by the C-terminus. 5 Previously, VCF was used to relate skeletal muscle Na + channel, Na V 1.4, VSD conformations to channel activation and inactivation [6] [7] [8] [9] [10] and to probe the domain-specific interactions of toxins [11] [12] [13] and local anesthetics. 14, 15 In this study, we present 4 novel constructs that report on the distinctive VSD conformations of Na V 1.5 for the purpose of assessing molecular mechanisms of Na V 1.5-linked pathologies and therapies. To demonstrate the potential of the method, we probe the molecular phenotype of 2 proximal BrS mutations, A735V and G752R, which are both located on the DII-VSD. The electrocardiographic phenotypes of patients with each mutation differ. Patients with A735V present with ST-segment elevation in leads V1-V3, 16 whereas those with G752R show ST-segment elevation 17 in addition to a prominent J wave in leads II, III, and aVF. 18 We hypothesized that in addition to electrocardiographic differences, there may also exist fundamentally different molecular pathologies, despite the proximity of the mutations.
Materials and Methods

Voltage-Clamp Fluorometry
cRNAs for human Na V 1.5 αand β 1 -subunits were injected into Xenopus laevis oocytes for cut-open oocyte recordings 19, 20 at 19°C. The internal solution was 105 mmol/L of NMG-Mes, 10 mmol/L of Na-Mes, 20 mmol/L of HEPES, and 2 mmol/L of EGTA, pH 7.4, and the external solution was composed of 25 mmol/L of NMG-Mes, 90 mmol/L of Na-Mes, 20 mmol/L of HEPES, and 2 mmol/L of Ca-Mes 2 , pH 7.4. For gating currents, 10 μmol/L of tetrodotoxin was used, and Na-Mes was replaced by NMG-Mes. For fluorescence recordings, oocytes were labeled with 10 µmol/L of methanethiosulfonate-carboxytetramethylrhodamine (MTS-TAMRA). Data were collected on a custom rig (Methods section in the Data Supplement). Animal procedures were performed according to institutional guidelines.
Data Analysis
For photobleaching correction, baseline fluorescence recorded over time without voltage pulsing was subtracted from traces recorded during the application of the voltage protocol. Fluorescence magnitude is expressed as ΔF/F 0 , ΔF is the signal amplitude change and F 0 is the baseline fluorescence.
Steady-state voltage dependence was quantified by Boltzmann function fitting: y=1/(1+exp[(V−V 1/2 )/k]). t 10%-90% for current activation is the duration between 10% and 90% of the ionic current peak. For fluorescence signals, t 10%-90%,C was calculated from the time constants of single exponential fits (τ).
Statistical comparisons were done using paired or independentsample t tests or 1-way ANOVA with post hoc tests for pairwise comparison. P<0.05 was considered significant. The ± symbols in the text and error bars in the figures represent the 95% confidence interval with the number of trials [n] in brackets.
Results
Our first aim was to create 4 Na V 1.5 constructs to track conformational changes within each of the Na V 1.5 channel VSDs. Initial attempts to record fluorescence signals were unsuccessful because of insufficient expression of human Na V 1.5, which is significantly reduced compared with rat Na V 1.4, the isoform used to acquire most existing Na + -channel VCF data. Examination of differences between the 2 channels revealed that Na V 1.5 contains an ubiquitination motif that enhances the channel recycling rate and reduces the number of channels in the membrane 21 ; this motif is not found in Na V 1.4. Ablation of the ubiquitination site by the Y1977A mutation and coinjection with β 1 -subunit RNA resulted in sufficient Na V 1.5 expression for the detection of useful fluorescence signals. We also introduced C373Y, increasing tetrodotoxin 22 sensitivity and allowing ionic current blockade for the measurement of gating currents. This mutation also removes an externally accessible cysteine, preventing nonspecific labeling.
Two protocols were performed to compare our new construct with wild-type (WT). We first quantified the conductance-voltage (G-V) relationship, found by measuring peak current after a series of depolarizing pulses and dividing by driving force. The second protocol measured the voltage dependence of steady-state inactivation (SSI); peak current was measured during a short test pulse to −20 mV that followed 200-ms inactivation-inducing pulses to varying potentials. The voltage dependence of the G-V and SSI curves was not substantially affected by these mutations (P=0.951 and 0.069, respectively; Figure 1 ). For fluorescence tracking, cysteine mutations (specified below) in the individual domains were introduced in this Y1977A-C373Y mutant, which we named WT-LFS (large fluorescence signal). The mutants produced for VSD tracking in this background will be accordingly referred to as DI-LFS, DII-LFS, DIII-LFS, and DIV-LFS. Cysteines were introduced at several positions within each VSD, but most of these did not produce useful signals. We were fortunate to find a single useful site for each domain.
To track the conformation of the DI-VSD, we tested 10 positions from L212 to T220 and R222. V215C (DI-LFS) was the only mutant to express well and produce a usable fluorescence signal ( Figure 2 ). The Na V 1.5 VSDs play an essential role in determining gating, and we expected the MTS-TAMRA labeling in conjunction with the introduced cysteine to affect gating to some extent. We observed a negative shift (ΔV 1/2 =−16.8 mV) in the G-V and a slight positive shift (ΔV 1/2 =+8 mV) in the SSI curves compared with the
WHAT IS KNOWN
• The cardiac Na + channel initiates atrial and ventricular action potentials, and inherited mutations that cause its dysfunction lead to syndromes that predispose patients to sudden death.
• Commonly prescribed class I antiarrhythmics that are targeted to the Na + channel can be effective for treating and diagnosing affected patients. However, the most effective drug choice for treating patients with a particular mutation is not always apparent.
WHAT THE STUDY ADDS
• We develop protocols to observe the voltage-sensing machinery that controls cardiac Na + -channel opening and closing to understand how inherited mutations pathologically alter the channel at the molecular level.
• Despite having similar ionic current phenotypes, we observed that 2 proximal Brugada syndrome mutations display different molecular characteristics. This improved phenotypic precision may eventually enable therapeutic approaches that specifically account for the molecular pathology of the arrhythmia.
background WT-LFS construct, implying that the labeled V215C channel opens at more negative potentials and inactivates at more positive potentials than WT-LFS. Comparing labeled and unlabeled DI-LFS showed that the G-V shift is a consequence of adding the MTS-TAMRA label ( Figure  I in the Data Supplement). We also used gating currents to assess whether charge movement across the transmembrane electric field was affected by labeling ( Figure II in the Data Supplement). If the probe significantly affected charge transfer, we would expect to observe a change in the voltage dependence of the gating current integral, the gating charge. For the 4 constructs, the charge-voltage (Q-V) relationship was shifted over a range of 5 to 11 mV in comparison with WT-LFS ( Figure I Table) , suggesting that charge displacement was modestly affected by cysteineconjugated fluorophore replacement of the WT residue.
Simultaneously, recording changes in fluorescence magnitude during these protocols allowed us to correlate DI-VSD conformations with channel gating. We refer to the fluorescence that was recorded during the G-V protocol as the fluorescence-voltage relationship (F-V curve) and the fluorescence from the SSI protocols as the SSI F-V curve. The F-V curves reflect the voltage dependence of the conformations in the DI-VSD that are reported by MTS-TAMRA. For the DI-VSD, the midpoint of the F-V curve was 27.2-mV negative of the G-V curve, indicating that DI-VSD movement occurs at much more negative potentials than pore opening. On the contrary, the SSI and SSI F-V curves had similar midpoints, showing that inactivation and DI-VSD movement occur in the same voltage range. However, in contrast to DIV, the DI-VSD SSI F-V and SSI slopes differed substantially (k=−15.4 [5] versus −6.4 [8] mV, respectively; P<0.001), suggesting that the 2 events are not tightly coupled.
The fluorescence kinetics recorded during the F-V curve reflect the voltage-dependent rates of VSD activation and deactivation. Because current and VSD activation kinetics are described by different functions, we measured the time between 10% and 90% of the peak current and calculated t 10%-90%,C for fluorescence (Methods section). DI-VSD rise time was slower (t 10%-90%,C =0.82±0.23 ms at +30 mV) than ionic current activation (t 10%-90% =0.24±0.04 ms), but the events overlapped because of the sigmoidal delay in ionic current activation ( Figure A, Top, Ionic currents. From −100 mV, a 50-ms step to −120 mV preceded 100-ms depolarizing pulses from −140 to +40 mV in 10-mV steps, which were followed by a 50-ms step to −120 mV before returning to holding potential. Membrane capacitance and leak were removed using P/−8 leak subtraction. For clarity, only the first 40 ms of traces corresponding to −130 to +30 mV in 20-mV steps are shown. Bottom, Voltage dependence of steady-state activation and steady-state inactivation (SSI) curves for the WT-LFS (G-V, black circles; SSI, black squares) and the WT channels (G-V, gray up triangle; SSI, gray down triangle). G-V curves were constructed from I-V relationships recorded from cells depolarized in 10-or 20-mV increments from −120 mV. Na + reversal potential was determined for each cell individually. For the SSI curve, cells were held at potentials ranging from −150 to +20 mV for 200 ms, and the available fraction was assessed by a −20-mV test pulse. Boltzmann-fit parameters are provided in the Table. B, Top, Gating currents from WT-LFS channels were recorded during 20-ms depolarizing steps ranging from −150 to +50 mV in 20-mV steps. Capacitance and leak were removed using P/4 leak subtraction with a subsweep holding level of +40 mV. Bottom, Gating currents were integrated for 10 ms after the voltage change.
of channels will not make this slow transition to a new state during a single action potential, channels may accumulate in this state at rapid heart rates.
Because fast inactivation is known to hinder the recovery of the gating charges on repolarization (immobilization), we performed experiments to measure the deactivation rate of the DI-VSD after depolarizing pulses of varying length, which inactivated the channels to different extents. The deactivation kinetics measured at −120 mV did not change as a function of pulse duration (t 10%-90%,C =0.99±0.22 ms after a 2-ms pulse and 0.99±0.13 ms after a 200-ms pulse [4] ; P=0.948). This result suggests that DI-VSD deactivation is not influenced by Na V 1.5 open-state inactivation, which had not occurred during the 2-ms pulse and is nearly complete after 200 ms.
We tracked the DII-VSD with S805C (DII-LFS), which yielded large and robust signals. The voltage-dependent steady-state parameters (G-V and SSI curves) were minimally affected in comparison with WT-LFS; there was no shift in the G-V curve and a +7.4-mV shift in the SSI curve ( Figure 3 ). Measurement of the F-V revealed that it was 12.5-mV negative of the G-V curve, showing that the DII-VSD starts to move before activation; however, it reaches saturation at higher potentials than the conductance because of its shallower slope, which indicates that the 2 events are not tightly coupled. Comparing the SSI and SSI-FV curves shows that inactivation occurs at more negative potentials than DII-VSD activation (V 1/2 =−79.2 and −52.2 mV, respectively) and that the inactivation slope is much steeper than DII-VSD activation . The mean±95% confidence interval for groups of 4 to 14 cells is reported. A, Top, Ionic currents (above) and fluorescence signals (below). From −100 mV, a 50-ms step to −120 mV preceded 20-ms-long depolarizing pulses ranging from −150 to +30 mV in 20-mV steps. These steps were then followed by a 50-ms step to −120 mV before returning to the holding potential. Membrane capacitance and leak were removed using P/−8 leak subtraction. For clarity, only traces corresponding to −150, −90, −30, and +30 mV are shown. Bottom, G-V curve (black circles) and steady-state inactivation (SSI; black squares) and the corresponding fluorescence signals (orange circles and squares, respectively). All curves were obtained by Figure 1 protocols. The fluorescence amplitude for the F-V and SSI F-V curves was determined by taking the mean of the signal for at least 3 ms at the greatest displacement of the signal. For the SSI F-V curve, ΔF was calculated as the difference between the signal amplitude measured at the conditioning potential and −20 mV. Boltzmannfit parameters are provided in the Table. Dotted lines represent WT-LFS G-V and SSI curves for comparison. B, Top, Tail currents and fluorescence measured at −120 mV after depolarizing steps to +50 mV for 2 (black) or 200 ms (orange). Inactivation does not occur during the shorter pulse resulting in a large tail current. Bottom, t 10%-90%,C values calculated from deactivation time constants of the fluorescence signal from exponential fits after the step back to −120 mV, from depolarizing steps to 0 or +50 mV for 1-to 200-ms durations.
(k=−6.5 [7] and −17.5 [6] mV, respectively; P<0.001). Thus, at holding potentials which completely abolish the conductance by inactivation (V>−50 mV), the DII-VSD is still far from having completed its motion, likely precluding it from participating in closed-state inactivation. The DI-VSD and DII-VSD activate at similar rates (t 10%-90%,C =0.98±0.19 ms at +30 mV [5] ; P=0.332), and when superimposed on the ionic current, DII-VSD activation precedes ionic current activation ( Figure III in the Data Supplement). As for DI, the DII-VSD deactivation kinetics are not substantially affected by the length of the depolarizing pulse (t 10%-90%,C =0.86±0.29 ms after 2 ms and 0.99±0.13 ms after 200 ms [4] ; P=0.171).
Conformations in the DIII-VSD were tracked with M1296C (DIII-LFS), which was the only construct to produce a signal out of I1299C, K1300C, and S1301C. The DIII construct had G-V and SSI curves nearly identical to those of DII, but relative to the DII-VSD, the F-V, and SSI F-V curves were dramatically shifted by −54.6 and −70.3 mV, respectively (Figure 4) . Comparison of the G-V and SSI curves shows that DIII-VSD activation precedes pore opening by a large voltage margin during activation, and similarly, during inactivation, most of the VSD movement is completed before any noticeable drop in the conductance because of inactivation. Activation kinetics of the DIII-VSD were similar to those of DI and DII (t 10%-90%,C =0.81±0.25 ms at +30 mV [5] ; P=0.332), although deactivation was >10× slower. Furthermore, in contrast to DI and DII, the deactivation kinetics of the DIII-VSD were significantly slowed when the duration of depolarizing pulse was increased (t 10%-90%,C =12.85±2.37 ms after a 2-ms pulse and 18.58±1.58 after 200 ms [6] ; P=0.009). The markedly slowed deactivation of the DIII-VSD after long depolarizations indicates that its return could be inhibited by entry of the channel into the deeper inactivated states that occur after longer depolarizations that stabilize it in the activated conformation.
Finally, to track the DIV-VSD, we introduced S1618C (DIV-LFS) and L1621C (no signal). The unlabeled DIV-LFS construct displays a nonsaturating SSI curve that is corrected by fluorophore conjugation. Recording of the unlabeled construct with a reducing agent confirmed that this phenomenon was because of disulphide bond formation in the absence of the fluorophore ( Figure I in the Data Supplement). Both the G-V and SSI curves of the DIV-VSD construct were shifted relative to WT-LFS by +5.3 and +12.4 mV, respectively ( Figure 5 ). Comparison of the fluorescence and ionic current shows that the midpoint of the F-V curve was 32.2 mV more negative than that of the G-V, whereas the SSI and SSI F-V curves overlapped, further supporting strong correlation between DIV-VSD activation and closed-state inactivation that is primarily measured by the SSI curve. In addition, slowing of fast inactivation caused by the introduction of the cysteine mutation is also readily apparent in the ionic current recordings. In comparison with the other 3 domains, the DIV fluorescence signal activated much more slowly (t 10%-90%,C =1.91±0.44 ms at +30 mV [7] ; P<0.001). Deactivation kinetics were significantly slower than those of the DI and DII but 2 to 3× faster than that of DIII. Surprisingly, DIV-VSD deactivation did not slow with increasing pulse duration (t 10%-90%,C =5.71±4.04 ms after a 2-ms pulse and 6.63±3.91 ms after 200-ms pulse [4] ; P=0.411). Given the prominent role of DIV in inactivation, the lack of slowing in DIV-VSD recovery with longer pulses is highly unexpected and is in clear contrast with Na V 1.4 results, 8 suggesting different interactions between the DIII-and DIV-VSDs and inactivation. Errors represent 95% confidence intervals and numbers in brackets indicate the number of cells measured. SSI indicates steady-state inactivation; and WT-LFS, wild-type large fluorescence signal, construct.
Table. Parameters of Boltzmann Fits to G-V, F-V, SSI, SSI F-V, and Q-V curves
Our next aim was to assess the molecular pathology of 2 proximal DII-VSD BrS mutations, A735V and G752R ( Figure 6 ). We introduced each into the DII-LFS construct. The F-V and SSI F-V curves of A735V were dramatically positive-shifted relative to DII-LFS (by +49.1 mV and +58.5 mV, respectively) and also relative to the G-V and SSI curves of the channel itself (by +19.5 mV and +89.1 mV, respectively). In addition, the voltage sensitivity of the DII-VSD was severely reduced; both had shallow slope factors (35.4 mV and −39.5 mV, respectively). DII-VSD activation kinetics were also slightly slowed by the mutation at +40 mV based on the t 10%-90%,C values (DII-LFS: 0.99±0.19 ms [8] and DII-LFS-A735V: 1.49±0.36 ms [5] ; P=0.005), but even more strikingly, the DII-VSD activation rate of the mutant lost its voltage dependence (1.45±0.42 ms at −20 mV and 1.49±0.36 ms at +40 mV [5] ; P=0.850) as opposed to DII-LFS (1.42±0.19 ms at −20 mV and 0.99±0.19 ms at +40 mV [8] ; P=0.002). To the contrary, ionic current activation of the mutant conserved its voltage dependence but was slower than DII-LFS at potentials <10 mV (t 10%-90% =1.48±0.17 ms [5] versus 0.71±0.47 ms [3] , respectively, at −20 mV; P=0.002). Despite the severely right-shifted F-V of A735V, the mutant Q-V (V 1/2 =−75.6±8.3 mV [5]) was not significantly different from that of DII-LFS (−80.0±7.6 mV [4] ; P=0.241) or WT-LFS (−69.1±4.2 mV [7] ; P=0.058).
In contrast, G752R caused minor F-V and SSI F-V shifts (by +1.0 mV and −9.8 mV, respectively, compared with DII-LFS) and displayed similar slope factors but resulted in a severe slowing of the DII-VSD activation. In response to a depolarizing step, the rate of DII-VSD activation was about 7-fold slower in the mutant than in the DII-LFS channel (t 10%-90%,C =0.99±0.19 ms [8] and 6.96±1.21 ms [8] at +40 mV, respectively; P<0.001). The Q-V curve was right-shifted by ≈20 mV with respect to DII-LFS. However, extending the interval over which charge was integrated from 10 to 20 ms, to account for G752R-induced slowing, shifted the curve leftward and closer to DII-LFS. Significant slowing of activation kinetics was also observed in the ionic current of G752R. In Figure 2 unless noted. The mean±95% confidence interval is reported for groups of 3 to 9 cells. A, Top, Ionic currents (above) and fluorescence (below). Bottom, G-V curve (black circles), steady-state inactivation (SSI; black squares), and the corresponding fluorescence (green circles and squares, respectively). Curves were constructed as in Figure 2 . Boltzmann-fit parameters are provided in the Table. Dotted lines represent wild-type G-V and SSI curves for comparison. B, Tail currents and fluorescence measured after the step back to −120 mV from depolarizing steps to +50 mV for 2 (black) or 200 ms (green). t 10%-90%,C values calculated from deactivation time constants of the fluorescence signal from exponential fits after the step back to −120 mV, from depolarizing steps to 0 or +50 mV for 1-to 200-ms durations.
the −40 to +30 mV voltage range, the activation rate was 1.7 to 2.9× slower than that of the DII-LFS as measured by the t 10%-90% times (1.51±0.15 ms [7] and 0.71±0.47 ms [3] , respectively, at −20 mV; P<0.001; Figure IV in the Data Supplement).
To ensure that the mechanisms we observed in oocytes are still operative across cell lines, we expressed both mutants in HEK293T cells. A comparison ( Figure V in the Data Supplement) shows that as in oocytes, current activation measured by the t 10%-90% was slowed in both BrS mutants compared with DII-LFS (at −20 mV, DII-LFS: 0.27±0.09 ms [4] , A735V: 0.81±0.32 ms [5] , G752R: 0.66±0.07 ms [4] ; P=0.002).
Discussion
Our results represent the first measurements of human Na V 1.5 VSD conformations and show that each VSD has unique kinetics, consistent with specific gating roles. Specifically, the 4 VSDs activate at different membrane potentials that span a range >50 mV. DIII activates at the most hyperpolarized potentials (V 1/2 =−106.0 mV), followed by DI (−83.9 mV), DIV (−66.8), and finally DII (−51.4), all negative of the G-V curve that characterizes current activation (V 1/2 =−39.9 mV for WT-LFS). Furthermore, all 4 VSDs have a t 10%-90 rise time that is slower than ionic current activation, which is to be expected if ionic current activation is caused by the combined motions of several VSDs that can be modeled as a cubed gate (eg, m 3 in Hodgkin-Huxley type models), allowing for a more rapid activation after a delay.
Although our results support the hypothesis of concerted action of several VSDs in activating Na V channels, our mutation results contrast to classical models that require tight coupling of the gates to pore opening. Comparing DII-VSD activation voltage dependence in A735V with its G-V relationship ( Figure 6A ) The mean±95% confidence interval is reported for groups of 5 to 17 cells. A, Top, Ionic currents (above) and fluorescence (below) were recorded during 20-ms pulses ranging from −170 to +30 mV in 20-mV steps. For clarity, only traces corresponding to −170, −110, −50, and +10 mV are shown. Bottom, G-V (black circles), steady-state inactivation (SSI; black squares), and the corresponding fluorescence signals (blue circles and squares, respectively). Curves were constructed as in Figure 2 . Boltzmann-fit parameters in Table. For comparison, dotted lines represent wild-type G-V and SSI curves. B, Tail currents and fluorescence measured after the step back to −120 mV from depolarizing steps to +50 mV for 2 (black) or 200 ms (green) pulses. Red dotted lines indicate exponential fits to the fluorescence traces. Time constants for this cell were 4.1 and 7.5 ms after 2-and 200-ms-long depolarizations, respectively. t 10%-90%,C values calculated from deactivation time constants of the fluorescence signal from exponential fits after the step back to −120 mV, from depolarizing steps to 0 or +50 mV for 1-to 200-ms durations. reveals that the channel fully opens at 0 mV, although the DII-VSD is not fully activated even at +80 mV. This phenomenon is observed in DII-LFS as well, indicating that this property is intrinsic to NaV1.5, but the effect is greatly enhanced in A735V. Thus, DII-VSD activation facilitates channel opening through an allosteric mechanism where the lack of VSD activation simply slows activation but does not prevent it. This mechanism may be evolutionarily beneficial because it allows for moderate alteration of VSD kinetics by mutations without preventing Na + channel activation and myocyte excitability.
Correlation of VSD activation with inactivation can be assessed by comparing the SSI and SSI F-V curves and pulse duration protocols. The SSI protocols show that the DII-VSD is least likely to participate in inactivation: at potentials, when the channel is completely blocked by inactivation, the DII-VSD has yet to significantly activate (Figure 3) . In contrast, the close overlap of the SSI and DIV SSI F-V curves supports the notion that the closed-state inactivation reported by this protocol is tightly coupled to DIV-VSD movement. Finally, the pulse duration protocol may reveal VSD interaction with deeper inactivation states that occur at depolarized potentials, which are likely to modulate the late Na + current.
Origin of ΔF
Our detected changes in MTS-TAMRA fluorescence emission are likely due to photoinduced electron transfer, which is a quenching nonradiative electron transfer between 2 molecules that are within 10 Å, in close van der Waals contact. 23 Many different residues may quench the fluorophore, which implies that our fluorescence signal is highly dependent on the surrounding residues that interact with the fluorophore as it moves. This dependence introduces the possibility that the fluorescence changes we observe do not necessarily reflect the movement of the charged S4 segments across the membrane.
Our Q-V curves that are calculated from gating currents directly quantify charge transfer within all 4 domains Figure 5 . DIV-large fluorescence signal (LFS; S1618C) ionic currents and fluorescence. Na + currents and fluorescence from DIV-LFS. The mean±95% confidence interval is reported for groups of 3 to 20 cells. A, Top, Ionic currents (above) and fluorescence (below) as in Figure 2 . Only traces from −150, −90, −30, and +30 mV are shown for clarity. G-V (black circles) and steady-state inactivation (SSI; black squares), and the corresponding fluorescence signals (purple circles and squares, respectively). Curves were constructed as in Figure 2 . Boltzmann-fit parameters are provided in the Table. Dotted lines represent wild-type G-V and SSI curves for comparison. B, Top, Tail currents and fluorescence measured during step back to −120 mV from steps to +50 mV for 2 (black) or 200 ms (green) pulses. Bottom, t 10%-90%,C values calculated from deactivation time constants of the fluorescence signal from exponential fits after the step back to −120 mV, from depolarizing steps to 0 or +50 mV for 1-to 200-ms durations.
across the membrane field. Thus, we expect that if we are tracking charge transfer, then the valence-weighted average midpoint of the F-V curves will match the Q-V curves (Figure 7 ; Table) . 6, 24 The WT-LFS Q-V is accurately reconstructed by the valence-weighted F-V curves ( Figure 7A) . Moreover, the confounding left shift in the A735V Q-V relative to G752R is also predicted by this analysis ( Figure 7B ) and results from much less charge being assigned to the DII F-V because of its reduced slope, which lessens its rightshifting contribution. With the G752R construct, we observe less charge transferred at some of the lower potentials. This slight difference is likely due to the substantial slowing of charge movement at these potentials, which sharply reduces the gating current and precludes its detection. Alternatively, G752R may be slowing the activation of the other 3 domains, causing a right-shifted Q-V. Previous work in Na V 1.4 shows that a DII-VSD activation shift modestly affects the activation of the DI, DIII, and DIV VSDs. 25 Future efforts to probe Na V 1.5 cooperativity will be needed to test whether this is the case for A735V and G752R.
A simple 2-state model of the VSD would predict that the SSI F-V is simply a mirror image of the F-V and that they should cross at 0.5. This is the case for the DI-and DII-VSDs but not for the DIII-and DIV-VSDs, which showed a lower crossing. Because the SSI F-V uses a 200-ms pulse, whereas the F-V is measured after several milliseconds, the difference is likely due to multiple activated or resting states of the VSD. This is not surprising, as multiple DIII-VSD resting states have been posited to model lidocaine interaction and we also infer multiple states from the pulse duration protocol. For the DIV-VSD, this crossing was in the range of experimental variability, but it may be linked to DIV-VSD interaction with inactivation.
Comparison With Previous Results
VCF has been used to study Na V 1.4, and many of the results have been extrapolated across the superfamily of Na V channels. Although we observe many similarities, there are several distinct Na V 1.5 features. In rNa V 1.4, the VSD activation midpoints all fell within a 20-mV range. In contrast, midpoints of the F-V curves for hNa V 1.5 spanned a range of ≈50 mV. In particular, DIII was activated at hyperpolarized potentials, and DII activation was substantially depolarized relative to the Q-V (by 30 mV). For the DII-VSD, this depolarizing shift may be because of loose coupling between the DII-VSD and channel activation, which was not observed in Na V 1.4.
Further differences are seen when comparing the connection between channel inactivation and VSD activation. Classical studies of Na V gating charge movement found that, after prolonged depolarization, a fraction of the gating charge is immobilized: that is, it returns with much slower kinetics on repolarization than the majority of the charge. 26 In human Na V 1.4, this immobilized fraction was associated with DIII and DIV. 8 Consistently, deactivation of hNa V 1.5 DI-VSD and DII-VSD was independent of the length of the depolarizing pulse. Conversely, return of the hNa V 1.5 DIII-VSD was significantly slowed by long depolarizations, whereas the DIV-VSD deactivation rate was unaffected, in clear contrast to Na V 1.4. However, this observation is in agreement with previous reports showing that charge immobilization of the Na V 1.5 DIV-VSD is independent of inactivation and that the inactivation particle can only modulate gating charge recovery of DIII but not DIV. 27 Thus, our data reconcile these 2 previously discrepant results by showing that the hNa V 1.5 VSDs interact with inactivation uniquely.
Many have previously probed the functional contributions of each VSD to Na V 1.5 gating, and our data show the timing of these contributions. For example, outward stabilization of the DI-S4 strongly reduced peak Na V 1.5 current (45%) without affecting rapid channel kinetics. 28 In our data, we observed a slow DI-VSD transition at elevated potentials that may be linked to this peak reduction through slow inactivation ( Figure 2) . In contrast, DII-VSD outward stabilization does affect rapid gating kinetics, shifting the G-V leftward along with SSI. 28 Our results show that this DII-VSD regulation of channel activation is through an allosteric connection, which facilitates channel opening when the DII-VSD is activated. Similar work has also probed the consequences of DIII and DIV-VSD outward stabilization, 29 both of which alter channel availability without affecting activation. Although the link between the 4 VSDs and inactivation is consistent with our results, it remains to be seen whether a slowing of DI, DIII, or DIV may also affect channel activation as observed in DII.
Relevance
For the inherited BrS mutations, A735V and G752R, we observed 2 different molecular pathologies ( Figure 6 ). A735V Figure 7 . Comparison of valence-weighted F-V functions with Q-V functions. F-V curves from each domain and the valenceweighted sum of these functions 24 (grey) are shown along with the Q-V curves (black) for wild-type large fluorescence signal (WT-LFS) (A), A735V (B), and G752R (C). For G752R, the 20-ms integral is shown ( Figure 6B ), and the F-V was also measured at 20 ms. clearly shifts the voltage dependence, whereas at positive potentials, DII-VSD activation kinetics are nearly as rapid as WT. In contrast, DII-VSD voltage dependence is preserved with G752R, but it arrives at its steady state much more slowly. For both mutants, the consequence for the ionic current is slower activation. Thus, our results show that dramatically different molecular pathologies can give rise to similar ionic current phenotypes. Still, molecular-level differences are likely to have significant consequences for the interaction of the channel with antiarrhythmic therapies.
From a theoretical perspective, the noncanonical Na V 1.5 activation mechanism revealed by the G752R and A735V mutations suggests a specific Markov state diagram where opening is possible from closed states where the VSDs are not yet activated. Recent work on L-type Ca 2+ channels revealed that this type of allosteric model was best suited to describe its data. Given the recent attention to similarities between Ca 2+ and Na + channels, it would not be surprising if a similar model would be more suitable for describing Na V 1.5 gating. We expect that future work probing the contribution of each VSD to channel gating will be immensely useful for informing these widely used models.
Future Directions
As demonstrated by our ability to observe the molecular pathology of 2 BrS mutations, we expect that we will be able to better understand mechanisms whereby some of the >150 Na V 1.5 inherited mutations cause disease. In addition, Na V 1.5 is known to interact with many accessory proteins, and it is tightly controlled by post-translational modification. By observing how these modulatory proteins and modifications affect the VSDs, we expect to unravel molecular mechanisms whereby the cell regulates hNa V 1.5 gating to modulate cardiac myocyte excitability.
